GlassScriptPhysician profile
Jeffrey K Rahe
NPI 1134122443
$1,649.55
in general payments reported to CMS, 2019-2025
21 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.93 · 2020: $221 · 2021: $294 · 2022: $402 · 2023: $261 · 2024: $138 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $377.49 | 2020-2025 | |
| Gynesonics, INC. | $298.80 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $289.03 | 2020-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $108.91 | 2020-2024 | Slynd |
| Coopersurgical, INC. | $79.99 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $67.20 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $59.11 | 2019-2020 | |
| Minerva Surgical, INC | $48.09 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.76 | 2021-2023 | |
| Pfizer INC. | $39.39 | 2020-2023 | |
| Hologic Sales and Service, LLC | $38.68 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Myovant Sciences INC. | $35.31 | 2021-2022 | |
| Sage Therapeutics, LLC | $22.98 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $22.98 | 2025 | Qelbree |
| Scynexis, INC. | $22.22 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $21.55 | 2022 | |
| Evofem Biosciences, INC. | $20.80 | 2021 | |
| Baxter Healthcare | $17.84 | 2022 | |
| Organon LLC | $14.22 | 2024 | |
| Amag Pharmaceuticals, INC. | $12.70 | 2019 | |
| Ascend Therapeutics US, LLC | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Rahe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.